<DOC>
	<DOCNO>NCT01170065</DOCNO>
	<brief_summary>The aim trial offer continuation BIBF 1120 treatment patient Idiopathic Pulmonary Fibrosis ( IPF ) complete prior clinical trial drug . The primary objective establish long term tolerability safety profile BIBF 1120 Idiopathic Pulmonary Fibrosis ( IPF ) . As secondary objective effect long term treatment BIBF 1120 survival well safety efficacy parameter investigate open-label , randomize , un-controlled design .</brief_summary>
	<brief_title>Roll Over Study From 1199.30 BIBF 1120 Idiopathic Pulmonary Fibrosis ( IPF )</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<mesh_term>Nintedanib</mesh_term>
	<criteria>Inclusion criterion : 1 . Patient primary diagnosis IPF ( accord 2000 American Thoracic Society/European Respiratory Society ( ATS/ERS ) criterion , willing continue trial medication . 2 . Written inform consent sign prior entry study , accordance International Conference HarmonisationGood Clinical Practice ( ICHGCP ) local law 3 . Completion 1199.30 study still treatment ( i.e . discontinue parent trial ) Exclusion criterion : 1 . Any disease may put patient risk participate trial . Reconsider carefully exclusion criterion trial 1199.30 . However , patient may qualify participation even though exclusion criterion may meet course participation 1199.30 , investigator 's benefitrisk assessment remain favourable . 2 . Participation another experimental clinical trial ( except 1199.30 ) last 8 week . 3 . Women breast feed child bear potential use highly effective method birth control least one month prior inclusion least 10 week end active therapy . Highly effective method birth control define result low failure rate ( i.e . le 1 % per year ) use consistently correctly , implant , injectables , combine oral contraceptive , Intra Uterine Devices ( IUDs ) , sexual abstinence vasectomize partner . Female patient consider childbearing potential unless surgically sterilize hysterectomy bilateral tubal ligation , postmenopausal least two year . 4 . Sexually active male commit use condom course study least 10 week end active therapy ( except partner childbearing potential ) . 5 . Patients require fulldose anticoagulation ( e.g . vitamin K antagonist , heparin , hirudin etc ) . 6 . Patients require fulldose antiplatelet ( e.g . acetyl salicylic acid , clopidogrel etc ) therapy . 7 . Known suspect active alcohol drug abuse . 8 . Patient compliant previous trial , trial medication trial visit .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>